KANGO SUJAY 4
4 · Dianthus Therapeutics, Inc. /DE/ · Filed Mar 5, 2025
Insider Transaction Report
Form 4
KANGO SUJAY
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-03-04+25,000→ 25,000 totalExercise: $19.86Exp: 2035-03-04→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award will vest as to one-third of the shares subject to the option on each of the first, second and third anniversaries of the date of grant, subject to the Reporting Person's continued service to the Issuer on each such vesting date.